Income Statement Wacker Chemie AG

Equities

WCH

DE000WCH8881

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:35:16 2025-07-09 am EDT			After hours 03:58:00 pm
69.45 ^EUR	+1.68%		70.00	+0.79%

06:21am	Wacker Chemie expands bio research in Munich	DP
Jul. 07	DZ Bank downgrades Wacker Chemie to 'Hold' – fair value €70	DP

3143c74104.iQWKHi9goNGpRvJ9PbQhjV9m9INws4lFPikweZ-e7BA.sE3Ybx4H873kdplKVOtRuzIhn-oo29wKTXoEHf3PiEK7XMArAlHXtZwexg

Published financial data: WACKER CHEMIE AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	4.69B	6.21B	8.21B	6.4B	5.72B
Total Revenues	4.69B	6.21B	8.21B	6.4B	5.72B
Cost of Goods Sold, Total	3.82B	4.54B	6.05B	5.32B	4.74B
Gross Profit	870M	1.67B	2.16B	1.08B	987M
Selling General & Admin Expenses, Total	458M	475M	548M	540M	574M
R&D Expenses	157M	164M	178M	184M	204M
Other Operating Expenses	-2M	-3M	-10.3M	51.7M	-36.4M
Other Operating Expenses, Total	613M	637M	716M	776M	741M
Operating Income	257M	1.04B	1.45B	307M	246M
Interest Expense, Total	-22M	-22.5M	-28.6M	-40.3M	-45.6M
Interest And Investment Income	11.4M	6.3M	10.9M	50M	41.5M
Net Interest Expenses	-10.6M	-16.2M	-17.7M	9.7M	-4.1M
Income (Loss) On Equity Invest.	34.9M	62.4M	201M	49.3M	19.1M
Currency Exchange Gains (Loss)	-7.8M	4.7M	-15.5M	1.1M	3.9M
Other Non Operating Income (Expenses)	-4.1M	-5.4M	-22.2M	-300K	-3.1M
EBT, Excl. Unusual Items	270M	1.08B	1.59B	367M	261M
Restructuring Charges	-48.9M	-100K	-	-	-
Impairment of Goodwill	-	-	-	-	-800K
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-2.6M	-3.2M	-4M	-12M	-8.8M
Asset Writedown	-1M	-700K	-	-	-9.2M
Insurance Settlements	900K	1.2M	500K	21.9M	500K
Other Unusual Items	-	15M	29.1M	10.5M	15.4M
EBT, Incl. Unusual Items	218M	1.09B	1.62B	387M	258M
Income Tax Expense	15.6M	266M	335M	59.7M	-2.3M
Earnings From Continuing Operations	202M	828M	1.28B	327M	261M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	202M	828M	1.28B	327M	261M
Minority Interest	-13.1M	-20.9M	-30.6M	-13.7M	-19.7M
Net Income - (IS)	189M	807M	1.25B	314M	241M
Net Income to Common Incl Extra Items	189M	807M	1.25B	314M	241M
Net Income to Common Excl. Extra Items	189M	807M	1.25B	314M	241M
Per Share Items
Net EPS - Basic	3.81	16.24	25.18	6.31	4.85
Basic EPS - Continuing Operations	3.81	16.24	25.18	6.31	4.85
Basic Weighted Average Shares Outstanding	49.68M	49.68M	49.68M	49.68M	49.68M
Net EPS - Diluted	3.81	16.24	25.18	6.31	4.85
Diluted EPS - Continuing Operations	3.81	16.24	25.18	6.31	4.85
Diluted Weighted Average Shares Outstanding	49.68M	49.68M	49.68M	49.68M	49.68M
Normalized Basic EPS	3.13	13.18	19.4	4.34	2.89
Normalized Diluted EPS	3.13	13.18	19.4	4.34	2.89
Dividend Per Share	2	8	12	3	2.5
Payout Ratio	13.11	12.32	31.77	190.08	61.83
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	628M	1.41B	1.81B	686M	677M
EBITA	267M	1.04B	1.46B	326M	267M
EBIT	257M	1.04B	1.45B	307M	246M
EBITDAR	637M	1.42B	1.82B	702M	693M
Effective Tax Rate - (Ratio)	7.16	24.3	20.7	15.43	-0.89
Current Domestic Taxes	-14.5M	203M	305M	-26.4M	23.8M
Current Foreign Taxes	30.3M	52.9M	67M	51.6M	36.4M
Total Current Taxes	15.8M	256M	372M	25.2M	60.2M
Deferred Domestic Taxes	-5.6M	34.7M	500K	900K	-30.1M
Deferred Foreign Taxes	5.4M	-24.4M	-38M	33.6M	-32.4M
Total Deferred Taxes	-200K	10.3M	-37.5M	34.5M	-62.5M
Normalized Net Income	155M	655M	964M	215M	144M
Interest Capitalized	200K	800K	2.6M	6.3M	6.7M
Interest on Long-Term Debt	3.9M	4.2M	9.3M	14.1M	17.3M
Non-Cash Pension Expense	27.9M	14.7M	21.9M	25.6M	25.6M
Supplemental Operating Expense Items
Selling and Marketing Expenses	291M	298M	342M	338M	349M
General and Administrative Expenses	140M	159M	183M	178M	201M
Research And Development Expense From Footnotes	157M	164M	178M	184M	208M
Net Rental Expense, Total	9.1M	10.4M	13.8M	15.1M	16.4M
Imputed Operating Lease Interest Expense	1.21M	1.36M	2.31M	3.69M	3.98M
Imputed Operating Lease Depreciation	7.89M	9.04M	11.49M	11.41M	12.42M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	626M	927M	895M	1.01B	1.05B
Short Term Investments	712M	739M	878M	348M	169M
Total Cash And Short Term Investments	1.34B	1.67B	1.77B	1.36B	1.22B
Accounts Receivable, Total	627M	825M	916M	789M	765M
Other Receivables	103M	141M	229M	191M	182M
Notes Receivable	40M	600K	2M	5.2M	1.9M
Total Receivables	770M	966M	1.15B	985M	949M
Inventory	880M	1.18B	1.66B	1.45B	1.8B
Prepaid Expenses	10.4M	12M	11.2M	24.5M	30.6M
Restricted Cash	-	-	100K	100K	100K
Other Current Assets, Total	581M	27.4M	73.5M	81.8M	65.1M
Total Current Assets	3.58B	3.85B	4.66B	3.9B	4.06B
Gross Property Plant And Equipment	10.89B	11.55B	12.37B	12.88B	13.67B
Accumulated Depreciation	-8.39B	-8.94B	-9.41B	-9.62B	-10.07B
Net Property Plant And Equipment	2.5B	2.61B	2.96B	3.26B	3.6B
Long-term Investments	61M	1.04B	1.2B	1.04B	1.04B
Goodwill	-	-	-	168M	171M
Other Intangibles, Total	21.1M	45.9M	213M	125M	117M
Loans Receivable Long-Term	-	-	-	21.3M	15.5M
Deferred Tax Assets Long-Term	771M	570M	273M	245M	270M
Other Long-Term Assets, Total	14.6M	25.4M	97.8M	95.2M	139M
Total Assets	6.95B	8.13B	9.4B	8.85B	9.41B
Liabilities
Accounts Payable, Total	424M	762M	886M	879M	852M
Accrued Expenses, Total	149M	250M	272M	150M	193M
Current Portion of Long-Term Debt	58M	347M	428M	387M	180M
Current Portion of Leases	24.8M	26.1M	33.1M	30.4M	40.8M
Current Income Taxes Payable	12.5M	69M	92.2M	44.6M	39.2M
Unearned Revenue Current, Total	64.4M	170M	93.7M	94.4M	82.8M
Other Current Liabilities	93.1M	88.2M	122M	178M	135M
Total Current Liabilities	826M	1.71B	1.93B	1.76B	1.52B
Long-Term Debt	1.22B	936M	858M	876M	1.44B
Long-Term Leases	98M	128M	228M	212M	290M
Unearned Revenue Non Current	71.1M	56.3M	226M	224M	219M
Pension & Other Post Retirement Benefits	2.71B	1.81B	769M	835M	752M
Deferred Tax Liability Non Current	9.1M	9.7M	35.6M	26.3M	24.2M
Other Non Current Liabilities	316M	379M	328M	338M	329M
Total Liabilities	5.26B	5.03B	4.37B	4.27B	4.57B
Common Stock, Total	261M	261M	261M	261M	261M
Additional Paid In Capital	157M	157M	159M	159M	158M
Retained Earnings	2.73B	3.43B	4.29B	4B	4.1B
Treasury Stock	-45.1M	-45.1M	-45.1M	-45.1M	-45.1M
Comprehensive Income and Other	-1.47B	-788M	202M	37.9M	198M
Total Common Equity	1.63B	3.02B	4.86B	4.42B	4.67B
Minority Interest	66.6M	81.9M	167M	163M	168M
Total Equity	1.69B	3.1B	5.03B	4.58B	4.84B
Total Liabilities And Equity	6.95B	8.13B	9.4B	8.85B	9.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	49.68M	49.68M	49.68M	49.68M	49.68M
ECS Total Common Shares Outstanding	49.68M	49.68M	49.68M	49.68M	49.68M
Book Value / Share	32.71	60.76	97.91	88.91	93.99
Tangible Book Value	1.6B	2.97B	4.65B	4.12B	4.38B
Tangible Book Value Per Share	32.29	59.84	93.62	83	88.18
Total Debt	1.41B	1.44B	1.55B	1.51B	1.95B
Net Debt	67.4M	-228M	-225M	144M	731M
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.71B	1.8B	663M	786M	631M
Debt Equivalent Oper. Leases	72.8M	83.2M	110M	121M	131M
Minority Interest, Total (Incl. Fin. Div)	66.6M	81.9M	167M	163M	168M
Equity Method Investments, Total	49.1M	709M	1B	950M	976M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	296M	397M	596M	505M	559M
Inventories - Work In Process, Total	582M	777M	1.06B	873M	1.15B
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	2.1M	3.1M	1.7M	71.4M	88.2M
Land - (BS)	1.6B	1.67B	1.76B	1.82B	2.01B
Machinery, Total	8.86B	9.25B	9.58B	9.76B	10.47B
Full Time Employees	14.28K	14.41K	15.72K	16.38K	12.82K
Part Time Employees	-	-	-	-	3.81K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	8.6M	15M	18.4M	22.7M	15.9M
Order Backlog	2.91B	6.59B	7.51B	6.38B	5.67B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	189M	807M	1.25B	314M	241M
Depreciation & Amortization - CF	392M	396M	387M	400M	451M
Amortization of Goodwill and Intangible Assets - (CF)	10.2M	7.4M	15.1M	19.2M	21.6M
Depreciation & Amortization, Total	402M	404M	402M	419M	473M
(Gain) Loss From Sale Of Asset	2.6M	3.3M	-3.4M	12M	8.8M
Asset Writedown & Restructuring Costs	1M	700K	-	-	-
(Income) Loss On Equity Investments - (CF)	-34.9M	-62.4M	-201M	-49.3M	-19.1M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	67.9M	43.3M	53.4M	90.8M	-9.6M
Change In Accounts Receivable	-21M	-185M	-67.6M	114M	34.1M
Change In Inventories	42.5M	-166M	-493M	159M	-369M
Change In Accounts Payable	-	-	88.6M	-49.2M	-51.9M
Change in Unearned Revenues	14.1M	90M	89.1M	-1.3M	-16.4M
Change in Other Net Operating Assets	210M	130M	6.2M	-72.7M	19.6M
Cash from Operations	874M	1.06B	1.13B	936M	310M
Capital Expenditure	-226M	-321M	-561M	-640M	-652M
Sale of Property, Plant, and Equipment	50.9M	46.8M	10.8M	1.1M	2.6M
Cash Acquisitions	-	-28.8M	-136M	-110M	-11.6M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-608M	-336M	-15.2M	662M	209M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-21.2M	4.9M
Other Investing Activities, Total	-	-	-	-	11.3M
Cash from Investing	-783M	-640M	-701M	-108M	-435M
Long-Term Debt Issued, Total	518M	2.4M	316M	407M	623M
Total Debt Issued	518M	2.4M	316M	407M	623M
Long-Term Debt Repaid, Total	-373M	-45.9M	-367M	-490M	-308M
Total Debt Repaid	-373M	-45.9M	-367M	-490M	-308M
Common Dividends Paid	-24.8M	-99.4M	-397M	-596M	-149M
Common & Preferred Stock Dividends Paid	-24.8M	-99.4M	-397M	-596M	-149M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-3.4M	-11M	-9.2M	-8.7M	-19.9M
Cash from Financing	117M	-154M	-458M	-688M	146M
Foreign Exchange Rate Adjustments	-17.5M	29.8M	2.5M	-21.6M	12M
Net Change in Cash	190M	301M	-31.9M	119M	33M
Supplemental Items
Cash Interest Paid	23.3M	21.6M	28.4M	39.7M	46.6M
Cash Income Tax Paid (Refund)	11.3M	151M	392M	58.3M	60.5M
Levered Free Cash Flow	85.54M	819M	148M	173M	-397M
Unlevered Free Cash Flow	99.29M	833M	166M	198M	-369M
Change In Net Working Capital	237M	-103M	578M	-227M	344M
Net Debt Issued / Repaid	145M	-43.5M	-51.9M	-83.3M	315M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.39	8.58	10.3	2.1	1.68
Return on Total Capital	5.03	16.96	16.25	3.03	2.38
Return On Equity %	10.87	34.55	31.52	6.81	5.54
Return on Common Equity	10.53	34.75	31.74	6.76	5.3
Margin Analysis
Gross Profit Margin %	18.54	26.94	26.32	16.92	17.24
SG&A Margin	9.77	7.66	6.67	8.44	10.03
EBITDA Margin %	13.39	22.67	22.03	10.72	11.83
EBITA Margin %	5.7	16.81	17.79	5.09	4.67
EBIT Margin %	5.48	16.69	17.6	4.79	4.29
Income From Continuing Operations Margin %	4.31	13.34	15.61	5.11	4.56
Net Income Margin %	4.03	13	15.24	4.9	4.21
Net Avail. For Common Margin %	4.03	13	15.24	4.9	4.21
Normalized Net Income Margin	3.31	10.55	11.74	3.36	2.51
Levered Free Cash Flow Margin	1.82	13.19	1.8	2.7	-6.95
Unlevered Free Cash Flow Margin	2.12	13.42	2.02	3.09	-6.45
Asset Turnover
Asset Turnover	0.7	0.82	0.94	0.7	0.63
Fixed Assets Turnover	1.78	2.43	2.95	2.06	1.67
Receivables Turnover (Average Receivables)	7.46	8.55	9.43	7.51	7.37
Inventory Turnover (Average Inventory)	4.11	4.41	4.27	3.43	2.92
Short Term Liquidity
Current Ratio	4.33	2.25	2.42	2.21	2.66
Quick Ratio	2.5	1.54	1.51	1.33	1.42
Operating Cash Flow to Current Liabilities	1.06	0.62	0.58	0.53	0.2
Days Sales Outstanding (Average Receivables)	49.08	42.68	38.7	48.6	49.68
Days Outstanding Inventory (Average Inventory)	89.02	82.76	85.47	106.53	125.4
Average Days Payable Outstanding	38.31	44.79	46.06	62.99	62.32
Cash Conversion Cycle (Average Days)	99.79	80.65	78.11	92.14	112.76
Long Term Solvency
Total Debt/Equity	83.08	46.34	30.75	32.87	40.25
Total Debt / Total Capital	45.38	31.67	23.52	24.74	28.7
LT Debt/Equity	78.18	34.32	21.58	23.76	35.67
Long-Term Debt / Total Capital	42.7	23.45	16.5	17.88	25.44
Total Liabilities / Total Assets	75.66	61.88	46.49	48.28	48.6
EBIT / Interest Expense	11.69	46.04	50.53	7.61	5.38
EBITDA / Interest Expense	29.98	63.97	64.59	18	15.75
(EBITDA - Capex) / Interest Expense	19.69	49.69	44.97	2.13	1.46
Total Debt / EBITDA	2.13	1	0.84	2.08	2.71
Net Debt / EBITDA	0.1	-0.16	-0.12	0.2	1.02
Total Debt / (EBITDA - Capex)	3.25	1.29	1.2	17.53	29.23
Net Debt / (EBITDA - Capex)	0.16	-0.2	-0.18	1.68	10.98
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.78	32.29	32.25	-22.01	-10.63
Gross Profit, 1 Yr. Growth %	25.94	92.26	29.2	-49.88	-8.89
EBITDA, 1 Yr. Growth %	15.35	124.07	28.48	-62.04	-1.38
EBITA, 1 Yr. Growth %	620.49	290.31	39.96	-77.67	-18.07
EBIT, 1 Yr. Growth %	966.8	302.92	39.5	-78.77	-19.98
Earnings From Cont. Operations, 1 Yr. Growth %	-132.13	309.19	54.82	-74.46	-20.35
Net Income, 1 Yr. Growth %	-129.44	326.48	55.04	-74.93	-23.15
Normalized Net Income, 1 Yr. Growth %	894.16	321.65	47.11	-77.64	-33.34
Diluted EPS Before Extra, 1 Yr. Growth %	-129.44	326.48	55.04	-74.93	-23.15
Accounts Receivable, 1 Yr. Growth %	-0.71	31.55	11.08	-13.93	-3.04
Inventory, 1 Yr. Growth %	-10.24	33.83	40.68	-12.48	23.9
Net Property, Plant and Equip., 1 Yr. Growth %	-9.4	4.06	13.64	10.12	10.29
Total Assets, 1 Yr. Growth %	7.08	17.03	15.58	-5.82	6.27
Tangible Book Value, 1 Yr. Growth %	-17.21	85.31	56.46	-11.34	6.24
Common Equity, 1 Yr. Growth %	-17.37	85.73	61.13	-9.19	5.71
Cash From Operations, 1 Yr. Growth %	44.41	21.83	5.74	-16.81	-66.85
Capital Expenditures, 1 Yr. Growth %	-45.43	41.85	74.67	13.97	1.88
Levered Free Cash Flow, 1 Yr. Growth %	-286.1	28.78	-81.94	16.73	-330.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-407.04	28.22	-80.1	19.34	-286.49
Dividend Per Share, 1 Yr. Growth %	300	300	50	-75	-16.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.92	12.24	32.27	1.56	-16.51
Gross Profit, 2 Yr. CAGR %	-0.27	55.61	57.61	-19.53	-32.43
EBITDA, 2 Yr. CAGR %	-9.96	60.77	69.67	-30.16	-38.82
EBITA, 2 Yr. CAGR %	3.86	430.3	133.73	-44.1	-57.23
EBIT, 2 Yr. CAGR %	4.73	555.62	137.08	-45.58	-58.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-11.81	14.66	151.7	-37.12	-54.9
Net Income, 2 Yr. CAGR %	-12.32	12.06	157.14	-37.66	-56.11
Normalized Net Income, 2 Yr. CAGR %	-9.7	547.44	149.05	-42.65	-61.39
Diluted EPS Before Extra, 2 Yr. CAGR %	-12.32	12.06	157.14	-37.66	-56.11
Accounts Receivable, 2 Yr. CAGR %	-4.11	14.28	20.88	-2.22	-8.65
Inventory, 2 Yr. CAGR %	-6.72	9.6	37.21	10.96	4.13
Net Property, Plant and Equip., 2 Yr. CAGR %	-15.72	-2.9	8.74	11.87	10.21
Total Assets, 2 Yr. CAGR %	-1.19	11.94	16.3	4.33	0.05
Tangible Book Value, 2 Yr. CAGR %	-27.47	23.86	70.27	17.78	-2.95
Common Equity, 2 Yr. CAGR %	-27.44	23.88	73	20.96	-2.02
Cash From Operations, 2 Yr. CAGR %	30.94	32.64	13.5	-6.21	-47.48
Capital Expenditures, 2 Yr. CAGR %	-25.56	-12.02	57.41	41.09	7.75
Levered Free Cash Flow, 2 Yr. CAGR %	-12.46	322.12	-51.77	-54.08	63.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	-11.51	407.55	-49.48	-51.27	49.18
Dividend Per Share, 2 Yr. CAGR %	-10.56	300	144.95	-38.76	-54.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.6	7.63	18.55	10.91	-2.68
Gross Profit, 3 Yr. CAGR %	-3.04	24.12	46.25	7.58	-16.13
EBITDA, 3 Yr. CAGR %	-12.86	22.01	49.19	3	-21.65
EBITA, 3 Yr. CAGR %	-10.44	61.47	240.16	6.84	-36.5
EBIT, 3 Yr. CAGR %	-10.53	64.1	291.41	6.07	-38.12
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.83	47.09	26.73	17.4	-31.96
Net Income, 3 Yr. CAGR %	-39.79	48.56	24.86	18.35	-33.16
Normalized Net Income, 3 Yr. CAGR %	-6.9	50.93	295.08	11.52	-39.7
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.57	48.56	24.86	18.35	-33.16
Accounts Receivable, 3 Yr. CAGR %	-1.48	6.55	13.21	7.94	-2.49
Inventory, 3 Yr. CAGR %	3.92	5.21	19.11	18.11	15.12
Net Property, Plant and Equip., 3 Yr. CAGR %	-10.57	-9.59	2.33	9.2	11.34
Total Assets, 3 Yr. CAGR %	0.56	4.55	13.14	8.4	4.98
Tangible Book Value, 3 Yr. CAGR %	-19.52	-0.84	33.89	36.98	13.8
Common Equity, 3 Yr. CAGR %	-19.53	-0.75	35.23	39.55	15.65
Cash From Operations, 3 Yr. CAGR %	9.96	27.83	22.99	2.33	-33.69
Capital Expenditures, 3 Yr. CAGR %	-11.63	-7.71	10.57	41.34	26.58
Levered Free Cash Flow, 3 Yr. CAGR %	-42.58	94.32	47.64	-35.25	-21.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.84	87.29	72.43	-32.72	-23.77
Dividend Per Share, 3 Yr. CAGR %	-7.17	47.36	188.45	14.47	-32.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.39	6.02	10.76	5.16	3.03
Gross Profit, 5 Yr. CAGR %	-5.08	15.24	17.75	4.36	7.39
EBITDA, 5 Yr. CAGR %	-7.61	9.86	13.75	-2.39	4.45
EBITA, 5 Yr. CAGR %	-5.65	30.69	31.45	5.64	48.41
EBIT, 5 Yr. CAGR %	-6.38	31.94	32.12	5.53	59.08
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.5	35.97	38.65	4.7	-16.17
Net Income, 5 Yr. CAGR %	-5.17	35.11	7.62	4.97	-17.81
Normalized Net Income, 5 Yr. CAGR %	-1.96	40.44	38	2.49	55.84
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.17	36.87	40.07	4.97	-17.81
Accounts Receivable, 5 Yr. CAGR %	-1.59	1.24	6.92	2.95	3.9
Inventory, 5 Yr. CAGR %	2.29	6.82	16.14	7.47	12.88
Net Property, Plant and Equip., 5 Yr. CAGR %	-12.2	-10.72	-3.29	-1.55	5.41
Total Assets, 5 Yr. CAGR %	-0.88	1.74	6.58	4.46	7.71
Tangible Book Value, 5 Yr. CAGR %	-8.75	5	8.61	6.22	17.72
Common Equity, 5 Yr. CAGR %	-8.75	4.87	9.29	7.43	18.88
Cash From Operations, 5 Yr. CAGR %	7.2	7.64	11.36	12.94	-12.49
Capital Expenditures, 5 Yr. CAGR %	-22.7	-5.11	11.33	9.37	9.44
Levered Free Cash Flow, 5 Yr. CAGR %	-8.29	40.63	-20.02	9.12	53.95
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.66	36.26	-19.14	9.31	62.73
Dividend Per Share, 5 Yr. CAGR %	0	31.95	36.85	3.71	37.97